Literature DB >> 12610111

The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.

Bin Gotoh1, Kenji Takeuchi, Takayuki Komatsu, Junko Yokoo.   

Abstract

Sendai virus (SeV) C protein functions as an interferon (IFN) antagonist and renders cells unresponsive to both alpha/beta IFN (IFN-alpha/beta) and IFN-gamma. We have recently found the physical association of the C protein with signal transducer and activator of transcription 1 (STAT1) in infected cells. However, involvement of the C-STAT1 interaction in the blockade of IFN signaling has remained unclear. We generated here a series of C mutant proteins that retained or lost the STAT1-binding capacity and examined their effects on IFN-alpha signaling. All of the C mutant proteins with no STAT1-binding capacity lost the ability to inhibit the IFN-alpha response. In contrast, the C mutant proteins retaining the STAT1-binding capacity suppressed IFN-alpha-stimulated tyrosine phosphorylation of both STAT2 and STAT1 to various degrees. Remarkably, their anti-IFN-alpha capacities correlated well with the inhibitory effect on phosphorylation of STAT2 rather than STAT1. In infected cells, the levels of tyrosine-phosphorylated (pY) STAT2 were below the detection level irrespective of duration of IFN-alpha stimulation, whereas the levels of pY-STAT1 strikingly increased after long-term IFN-alpha stimulation. These results suggest that the STAT2 activation process is a crucial target for the blockade of IFN-alpha signaling. An in vitro binding assay with extracts from (STAT1-deficient) U3A and (STAT1-expressing) U3A-ST1 cells suggested the requirement of STAT1 for the C-STAT2 interaction. Furthermore, expression of STAT1 enhanced the inhibitory effect of the C protein on STAT2 activation in U3A cells. The C protein thus appears to participate in the inhibitory process for STAT2 activation through the STAT1 interaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610111      PMCID: PMC149518          DOI: 10.1128/jvi.77.6.3360-3370.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses.

Authors:  A García-Sastre
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

Review 2.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

3.  C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha.

Authors:  T Kubota; N Yokosawa; S Yokota ; N Fujii
Journal:  Biochem Biophys Res Commun       Date:  2001-04-27       Impact factor: 3.575

4.  Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells.

Authors:  D F Young; N Chatziandreou; B He; S Goodbourn; R A Lamb; R E Randall
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation.

Authors:  H Asao; X Y Fu
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

6.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.

Authors:  A Kato; Y Ohnishi; M Kohase; S Saito; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription.

Authors:  T Komatsu; K Takeuchi; J Yokoo; Y Tanaka; B Gotoh
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Sendai virus C proteins must interact directly with cellular components to interfere with interferon action.

Authors:  D Garcin; J Curran; D Kolakofsky
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.

Authors:  D F Young; L Didcock; S Goodbourn; R E Randall
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

View more
  51 in total

1.  Virus-driven conditional expression of an interferon antagonist as a tool to circumvent host restriction.

Authors:  Denis Gerlier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor.

Authors:  Jean-Baptiste Marq; Albert Brini; Daniel Kolakofsky; Dominique Garcin
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

Review 4.  Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses.

Authors:  Srirupa Chatterjee; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  J Mol Biol       Date:  2016-07-31       Impact factor: 5.469

5.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

6.  Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7- and TLR9-dependent interferon induction.

Authors:  Yoshinori Kitagawa; Mayu Yamaguchi; Min Zhou; Machiko Nishio; Masae Itoh; Bin Gotoh
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

7.  Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function.

Authors:  Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

Authors:  Jacquelyn R Bedsaul; Luna A Zaritsky; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2016-08-10       Impact factor: 2.607

9.  Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.

Authors:  Kosuke Oda; Yasuyuki Matoba; Takashi Irie; Ryoko Kawabata; Masaya Fukushi; Masanori Sugiyama; Takemasa Sakaguchi
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.